The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Schizophrenia: Diverse Approaches to a Complex Disease
Abstract
Schizophrenia is a debilitating mental illness that affects 1% of the population. Despite intensive study, its molecular etiology remains enigmatic. Like many common diseases, schizophrenia is multifactorial in origin, with both genetic and environmental contributions likely playing an important role in the manifestation of symptoms. Recent advances based on pharmacological studies, brain imaging analyses, and genetic research are now converging on tantalizing leads that point to a central role for several neurotransmitters, including dopamine, glutamate, and serotonin, that may interface with neurodevelopmental defects reflecting disease-related genetic aberrations. Here, we provide a brief overview of the parallel approaches being used to identify the molecular causes of schizophrenia and discuss possible directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Self-citationThe neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Husband, J., & Kreel, L. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90890-4 · Cited by 1,253
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,206
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
Cited by
Kim, J.-H., Auerbach, J. M., Rodríguez-Gómez, J. A., Velasco, I., Gavin, D., Lumelsky, N., Lee, S.-H., Nguyen, J., Sánchez-Pernaute, R., Bankiewicz, K., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,607
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,124
The Life Course and Human Development
Elder, G. H., & Shanahan, M. J. (2007) · Handbook of Child Psychology · doi:10.1002/9780470147658.chpsy0112 · Cited by 1,062
Identification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803
Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology
TANDON, R., KESHAVAN, M., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.011 · Cited by 720
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609
Self-citationMatthews, G., Deary, I. J., & Whiteman, M. C. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511812736 · Cited by 541
A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development
Kamiya, A., Kubo, K.-I., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1328 · Cited by 531
Self-citationVariation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia
Callicott, J. H., Straub, R. E., Pezawas, L., Egan, M. F., Mattay, V. S., Hariri, A. R., Verchinski, B. A., Meyer-Lindenberg, A., Balkissoon, R., Kolachana, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500515102 · Cited by 516
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
ABEL, T., & ZUKIN, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.002 · Cited by 494
Rosenfield, S., & Mouzon, D. (2013) · Handbooks of Sociology and Social Research · doi:10.1007/978-94-007-4276-5_14 · Cited by 494
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 472
Social Context in Gene–Environment Interactions: Retrospect and Prospect
Shanahan, M. J., & Hofer, S. M. (2005) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/60.special_issue_1.65 · Cited by 439
Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426
“Altered DA signaling is associated with numerous psychiatric disorders, including schizophrenia (34).”
BackgroundGraph theory and networks in Biology
Mason, O., & Verwoerd, M. (2007) · IET Systems Biology · doi:10.1049/iet-syb:20060038 · Cited by 398
Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., Okawa, M., Yamada, N., Hatten, M. E., Snyder, S. H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136913100 · Cited by 392
Self-citationBeyond Mendel: an evolving view of human genetic disease transmission
Badano, J. L., & Katsanis, N. (2002) · Nature Reviews Genetics · doi:10.1038/nrg910 · Cited by 366
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
Stone, J. M., Morrison, P. D., & Pilowsky, L. S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073126 · Cited by 348
Effects of Toxoplasma on Human Behavior
Flegr, J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl074 · Cited by 330
The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
Guloksuz, S., & van Os, J. (2018) · Psychological Medicine · doi:10.1017/s0033291717001775 · Cited by 325
Diverse Psychotomimetics Act Through a Common Signaling Pathway
Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 314
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth
Miyoshi, K., Honda, A., Baba, K., Taniguchi, M., Oono, K., Fujita, T., Kuroda, S., Katayama, T., & Tohyama, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001352 · Cited by 314
López-Figueroa, A. L., Norton, C. S., López-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., López, J. F., & Watson, S. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.017 · Cited by 296
Standardized remission criteria in schizophrenia
van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Bernardo, M., Arango, C., Fleischhacker, W., Lachaux, B., et al. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00659.x · Cited by 285
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Kurita, M., Holloway, T., García-Bea, A., Kozlenkov, A., Friedman, A. K., Moreno, J. L., Heshmati, M., Golden, S. A., Kennedy, P. J., Takahashi, N., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3181 · Cited by 285
Lane, H.-Y., Chang, Y.-C., Liu, Y.-C., Chiu, C.-C., & Tsai, G. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1196 · Cited by 271
Link, B. G., & Phelan, J. C. (2013) · Handbooks of Sociology and Social Research · doi:10.1007/978-94-007-4276-5_25 · Cited by 269
Osimo, E. F., Beck, K., Reis Marques, T., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0041-5 · Cited by 268
Loder, M. K., & Melikian, H. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301845200 · Cited by 260
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Huang, H., Oishi, K., Mori, S., Smee, D. F., Pearce, D. A., Winter, C., Sohr, R., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.018 · Cited by 250
A Review of Disrupted-in-Schizophrenia-1 (disc1): Neurodevelopment, Cognition, and Mental Conditions
Ishizuka, K., Paek, M., Kamiya, A., & Sawa, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.065 · Cited by 190
Self-citationReelin and neuropsychiatric disorders
Ishii, K., Kubo, K.-I., & Nakajima, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00229 · Cited by 185
Early human brain development: Starring the subplate
Hadders-Algra, M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.017 · Cited by 100
Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia
Martins-de-Souza, D. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.007 · Cited by 81
Michaelovsky, E., Gothelf, D., Korostishevsky, M., Frisch, A., Burg, M., Carmel, M., Steinberg, T., Inbar, D., Apter, A., & Weizman, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008085 · Cited by 53
Tian, L., Meng, C., Yan, H., Zhao, Q., Liu, Q., Yan, J., Han, Y., Yuan, H., Wang, L., Yue, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028794 · Cited by 44
Yuen, E. Y., Li, X., Wei, J., Horiguchi, M., Meltzer, H. Y., & Yan, Z. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076141 · Cited by 38
Retromer in Synaptic Function and Pathology
Brodin, L., & Shupliakov, O. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00037 · Cited by 29
Environmental exposure to metals, neurodevelopment, and psychosis
Modabbernia, A., Arora, M., & Reichenberg, A. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000332 · Cited by 28
So, H., Fong, P. Y., Chen, R. Y. L., Hui, T. C. K., Ng, M. Y. M., Cherny, S. S., Mak, W. W. M., Cheung, E. F. C., Chan, R. C. K., Chen, E. Y. H., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30961 · Cited by 28
Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure
Wang, X., Gu, Z., Zhong, P., Chen, G., Feng, J., & Yan, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.08.018 · Cited by 16
The Incorporation of a Spiritual Emergency Experience Into a Client’s Worldview: A Grounded Theory
Sedláková, H., & Řiháček, T. (2019) · Journal of Humanistic Psychology · doi:10.1177/0022167816668114 · Cited by 1
Metadata
- Authors
- Sawa, A., & Snyder, S. H.
- Venue
- Science
- Published
- 2002-04-26
- Volume
- 296
- Issue
- 5568
- Pages
- 692-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2019363012
- Cited by
- 597
- References
- 34
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.